ABSTRACT
The cloning of Dolly the sheep, more than ten years ago, was widely seen as a major achievement of the scientific community and many potential beneficiaries of cloning, within both human biomedicine and food production, quickly came to entertain great hopes so far as applications of the technology were concerned. At the same time, however, concerns were raised about ethical implications. Until Dolly, conventional scientific wisdom had been that the cloning of cells taken from the somatic tissue of adult individuals was impossible. The advent of Somatic Cell Nuclear Transfer (SCNT) changed that. This chapter examines a range of wider concerns about farm animal cloning. Ways of addressing these concerns through regulation and law, particularly in the European setting, are discussed. Various possible developments of applications and ensuing regulatory options (involving, principally, existing regulation, new EU regulation and national regulation) are explored.
